SCHEMBL1602869

SCHEMBL1602869

O[C@@H]1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL57383 1.00
SCHEMBL2983504 1.00
Hydrochloric Acid SCHEMBL6283604 0.97
Hydrochloric Acid SCHEMBL1047426 0.97
Hydrochloric Acid SCHEMBL1047427 0.97
Methane SCHEMBL1189865 0.97
SCHEMBL69143 0.93
SCHEMBL3504272 0.91 NOS2 (0.36)
Methane SCHEMBL705841 0.90
Hydrochloric Acid SCHEMBL16777052 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12208088-B2 Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof GENENTECH, INC. (US) 2025-01-28 US disclosed
US-20220370420-A1 SPIROCYCLIC 2,3-DIHYDRO-7-AZAINDOLE COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2022-11-24 US disclosed
CN-114409585-A 2-oxopyrrolidine derivatives, process for preparing the same and process for preparing intermediates 凯莱英医药集团(天津)股份有限公司 2022-04-29 CN disclosed
CN-114409585-A 2-oxopyrrolidine derivatives, process for preparing the same and process for preparing intermediates 凯莱英医药集团(天津)股份有限公司 2022-04-29 CN disclosed
CN-113015526-A Spirocyclic 2, 3-dihydro-7-azaindole compounds and uses thereof 豪夫迈·罗氏有限公司 2021-06-22 CN disclosed
US-20200157545-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF WAVE LIFE SCIENCES LTD. (SG) 2020-05-21 US disclosed
US-9937151-B2 Carbapenem antibacterials with gram-negative activity FOB SYNTHESIS, INC. (US) 2018-04-10 US disclosed
EP-2590978-B1 CARBAPENEM ANTIBACTERIALS WITH GRAM-NEGATIVE ACTIVITY FOB SYNTHESIS INC (US) 2017-09-20 EP disclosed
EP-2861750-B1 PROCESS FOR PRODUCING CHIRAL 1-SUBSTITUTED 3-PIPERIDINOLS EMPLOYING OXIDOREDUCTASES LABORATORIO CHIMICO INT SPA (IT) 2016-11-23 EP disclosed
US-9464076-B2 Benzothiophene derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-10-11 US disclosed
WO-2004056766-A1 INHIBITORS OF TACE VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-07-08 WO disclosed
EP-0900787-B1 PROCESS FOR PREPARING PYRROLIDINE DERIVATIVES KANEKA CORP (JP) 2002-09-11 EP disclosed
EP-0714299-B1 BENZOXAZINONE AND BENZOPYRIMIDINONE PIPERIDINYL TOCOLYTIC OXYTOCIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2002-04-24 EP disclosed
US-6166015-A Pyrrolidine derivatives-CCR-3 receptor antagonists SYNTEX (U.S.A.) INC. (US) 2000-12-26 US disclosed
US-5665719-A Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists MERCK & CO., INC. (US) 1997-09-09 US disclosed
EP-0381984-B1 3- or 4-substituted oxotremorine derivatives AMERICAN CYANAMID CO (US) 1995-04-19 EP disclosed
US-5089518-A 3- or 4-substituted oxotremorine derivatives and a method of treating cholinergic dysfunction therewith AMERICAN CYANAMID COMPANY (US) 1992-02-18 US disclosed
US-4952600-A TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM AMERICAN CYANAMID COMPANY (US) 1990-08-28 US disclosed
EP-0381984-A1 3- or 4-substituted oxotremorine derivatives AMERICAN CYANAMID COMPANY (US) 1990-08-16 EP disclosed
US-4937235-A Anticholinergic agents AMERICAN CYANAMID COMPANY (US) 1990-06-26 US disclosed